Diagnosis of Pneumonia in Immunocompromised Patient

Baughman, Robert P.; Lower, Elyse E.

doi:10.1002/9780470714171.ch3

Cited by 4 publications

(3 citation statements)

References 196 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…ADENIRAN, G. A compromised immune system can also lead to pneumonia which is also more prone to individuals with old age or respiratory problems than healthy people (Aleem et al, 2021, Dipo et al, 2023, Fekadu et al, 2023and Marcus et al, 2021. As the body sends white blood cells to attack the infection, the sacs become filed with fluid and pus -causing pneumonia.…”

Section: Olopade I A; Akinola E I; Philemon M E; Mohammed I T; Ajao S...mentioning

confidence: 99%

Modeling the Mathematical Transmission of a Pneumonia Epidemic Model with Awareness

Olopade,

Akinola,

Philemon

et al. 2024

jasem

View full text Add to dashboard Cite

A new model for the transmission of a pneumonia epidemic, considering awareness and a mass action incidence function, is presented. Stability analyses for disease-free and endemic equilibrium points are conducted. The Basic Reproduction Number (Ro) for pneumonia with awareness is defined and analyzed, showing stability when (Ro < 1) and transitioning to an endemic state when (Ro > 1) . Additionally, a special case is highlighted where the Basic Reproduction Number (Ro*) (without awareness) is greater than (Ro). Basic Reproduction Number with awareness, i.e. (Ro* = 1.0965 > Ro = 0.8772). Furthermore, a numerical simulation is provided to depict how awareness influences the dynamic management of the disease. The results underscore the crucial role of awareness in educating the public about infection risks, ultimately contributing to a decrease in the health burden by mitigating the epidemic peak.

show abstract

Section: Olopade I A; Akinola E I; Philemon M E; Mohammed I T; Ajao S...mentioning

confidence: 99%

Modeling the Mathematical Transmission of a Pneumonia Epidemic Model with Awareness

Olopade,

Akinola,

Philemon

et al. 2024

jasem

View full text Add to dashboard Cite

show abstract

“…The decision to use cartilage grafts in immunocompromised individuals requires careful consideration of the potential impact on healing and the heightened susceptibility to complications. Surgeons must collaborate closely with immunologists and other specialists to assess the patient's immune status and implement tailored strategies to mitigate risks and optimize outcomes in cartilage graft procedures [31].…”

Section: Medical Conditionsmentioning

confidence: 99%

Cartilage’s Contribution in Otology: A Comprehensive Review of Its Role in Ear Surgery

Kakkad,

Deshmukh,

Gaurkar

2023

Cureus

View full text Add to dashboard Cite

This comprehensive review thoroughly examines the pivotal role of cartilage in otologic surgery, elucidating its multifaceted contributions to both cosmetic and functional outcomes. From reconstructing the external ear to reinforcing the tympanic membrane and restoring the ossicular chain, cartilage emerges as a versatile and resilient biological material with unique properties that make it an invaluable resource for otologic surgeons. The review explores the nuances of cartilage's applications in various surgical contexts, emphasizing its significance in promoting tissue regeneration and healing. The text delves into advancements in tissue engineering, biodegradable scaffolds, and 3D printing technology, pointing toward a future where more precise and personalized interventions may redefine the landscape of otologic surgery. The convergence of these innovations holds the promise of elevating the standard of care, minimizing complications, and improving the quality of life for patients undergoing cartilage-based otologic procedures. This synthesis of current knowledge and future possibilities provides a valuable resource for otologists, surgeons, and researchers in the dynamic field of otology.

show abstract

“…Even before the pandemic, the Global Burden of Diseases, Injuries and Risk Factors Study reported rising acute respiratory infection incidence, with an estimated 489 million cases and 2.5 million deaths worldwide in 2019 1 . Well‐established risk factors for respiratory infection include low socio‐economic status, malnutrition, smoking, air pollution, advanced age, immunosuppression and immunodeficiency 1–4 . One of the genetic markers often associated with disease is the ABO blood grouping system.…”

Section: Introductionmentioning

confidence: 99%

Association of ABO and Rhesus blood groups with severe outcomes from non‐SARS‐CoV‐2 respiratory infection: A prospective observational cohort study in Bristol, UK 2020–2022

Hathaway,

Qian,

King

et al. 2023

Br J Haematol

View full text Add to dashboard Cite

SummaryDespite significant global morbidity associated with respiratory infection, there is a paucity of data examining the association between severity of non‐SARS‐CoV‐2 respiratory infection and blood group. We analysed a prospective cohort of adults hospitalised in Bristol, UK, from 1 August 2020 to 31 July 2022, including patients with acute respiratory infection (pneumonia [n = 1934] and non‐pneumonic lower respiratory tract infection [NP‐LRTI] [n = 1184]), a negative SARS‐CoV‐2 test and known blood group status. The likelihood of cardiovascular complication, survival and hospital admission length was assessed using regression models with group O and RhD‐negative status as reference groups. Group A and RhD‐positive were over‐represented in both pneumonia and NP‐LRTI compared to a first‐time donor population (p < 0.05 in all); contrastingly, group O was under‐represented. ABO group did not influence cardiovascular complication risk; however, RhD‐positive patients with pneumonia had a reduced odds ratio (OR) for cardiovascular complications (OR = 0.77 [95% CI = 0.59–0.98]). Compared to group O, group A individuals with NP‐LRTI were more likely to be discharged within 60 days (hazard ratio [HR] = 1.17 [95% CI = 1.03–1.33]), while group B with pneumonia was less likely (HR = 0.8 [95% CI = 0.66–0.96]). This analysis provides some evidence that blood group status may influence clinical outcome following respiratory infection, with group A having increased risk of hospitalisation and RhD‐positive patients having reduced cardiovascular complications.

show abstract

Diagnosis of Pneumonia in Immunocompromised Patient

Cited by 4 publications

References 196 publications

Modeling the Mathematical Transmission of a Pneumonia Epidemic Model with Awareness

Modeling the Mathematical Transmission of a Pneumonia Epidemic Model with Awareness

Cartilage’s Contribution in Otology: A Comprehensive Review of Its Role in Ear Surgery

Association of ABO and Rhesus blood groups with severe outcomes from non‐SARS‐CoV‐2 respiratory infection: A prospective observational cohort study in Bristol, UK 2020–2022

Contact Info

Product

Resources

About